Multiple Sclerosis (MS) Drugs

| Avonex | Betaseron | Betaferon | Copaxone | Rebif |

Additional Reading

Arthritis during interferon beta-1b treatment in multiple sclerosis

"Arthritis during interferon beta-1b treatment in multiple sclerosis"

Altintas A, Alici Y, Melikoglu M, Siva A.

Department of Neurology, Cerrahpasa School of Medicine, 34300 Istanbul, Turkey. aaltintas.md@superonline.com

Interferon beta (IFN-beta) is the most widely prescribed disease-modifying drug for multiple sclerosis (MS). Therapy with IFN-beta may be associated with a number of adverse reactions.

The development or exacerbation of other autoimmune diseases is a rare but reported side effect of IFN-beta therapy.

In this case report, we present clinical and laboratory findings of two MS patients who developed arthritis during IFN-beta1b treatment, probably of autoimmune origin.

Mult Scler. 2002 Dec;8(6):534-6.

PMID: 12474998 [PubMed link]

 

 

Multiple Sclerosis

Multiple sclerosis (ms) is the most common, disabling, neurological condition, to affect young adults in the world today.

Early Symptoms

The nature of multiple sclerosis and the vagueness of a symptom appearing here or there over time, without any apparent connection means there is a lack of data on what can accurately be considered as early symptom of multiple sclerosis... Read More